It took Virginia Cancer Specialists nearly 1 year to get the supervised case experience needed to fulfill regulation ...

For many women in the United States who encounter drenching night sweats, sudden hot flashes, debilitating exhaustion and ...

Hematological malignancies encompass a diverse range of diseases, such as leukemia, lymphoma, and multiple myeloma, among others. Within the multidisciplinary treatment approach, radiation therapy ...

Survivorship is a relational shift for the whole family, not a return to pre-cancer life. Fear of recurrence affects the ...

NCCN updates recommend cabozantinib for neuroendocrine tumors, offering flexibility in treatment options based on patient needs and prior therapies. This segment focuses on systemic treatment ...

Anti–PD-1 therapy (pembrolizumab, nivolumab) supports neoadjuvant and adjuvant management of higher-risk melanoma, offering durable remissions with less systemic toxicity than traditional chemotherapy ...

A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in people with progressive and treatment-resistant systemic sclerosis (SSc), ...

As hiring slows across much of the U.S., a handful of jobs are standing out for their resilience. Roles that rely on hands-on expertise and human connection are proving particularly durable, according ...

In the Federal Reserve's battle between fighting inflation and unemployment, the latter side carried the day Wednesday and could also have an edge heading into 2026. At his Wednesday news conference, ...

I was hoping to grow in my career, so I quit my job when I landed a better position. But that new job fired me, and I was left to search for something new. Now I'm working in a new field and ...

(RTTNews) - Citius Oncology, Inc. (CTOR), the oncology subsidiary of Citius Pharmaceuticals Inc. (CTXR) announced the U.S. commercial launch of LYMPHIR, a new immunotherapy for adults with relapsed or ...

Systemic therapy is often given late due to optimism bias, treatment momentum, and difficulty in end-of-life conversations, leading to increased hospitalizations and ICU admissions. MD Anderson Cancer ...